All results

161 results for tests

• Meteoroid

  The main objective of the study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of…

  Ages

  12 Years - N/A

  Sexes

  All

• L. johnsonii in adult with T1D

  While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in…

  Ages

  18 Years - 45 Years

  Sexes

  All

• ToPP-UP

  This proposed research is relevant to human health because preemptive clinical pharmacogenetic testing may improve the personalization of drug therapy which…

  Ages

  18 Years - N/A

  Sexes

  All

• Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE)

  Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology…

  Ages

  18 Years - N/A

  Sexes

  All

• A Pilot Study of Rapid Haplotyping procedure for Personalized Dosing of Dichloroacetate (DCA) in Hea

  The purpose of this study is to identify and analyze the frequency of GSTZ1 haplotypes in a healthy adult population and determine the pharmacokinetics of…

  Ages

  18 Years - 70 Years

  Sexes

  All

• ADOPT PGx

  This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…

  Ages

  8 Years - N/A

  Sexes

  All

• A Study of ASP1002 in Adults for Treatment of Solid Tumors

  ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…

  Ages

  18 Years - N/A

  Sexes

  All

• PD GENE

  Development of a central repository for PD-related genomic data for future research. The purpose of this study is to develop a central repository for…

  Ages

  18 Years - N/A

  Sexes

  All

• 1305-0023 (FIBRONEERTM ILD)

  This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…

  Ages

  18 Years - N/A

  Sexes

  All

• 1305-0014 (FIBRONEERTM IPF)

  This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they…

  Ages

  40 Years - N/A

  Sexes

  All